Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors
- PMID: 36564582
- DOI: 10.1007/s12022-022-09745-x
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors
Abstract
The incidence of well-differentiated non-functioning pancreatic neuroendocrine tumors (NF-PanNET) increased during the last decades. The risk of relapse after curative surgery, albeit low, is not negligible; moreover, adjuvant treatment is currently not an option and a reliable predictive model based on prognostic characteristics is urgently needed for tailoring a follow-up strategy. The histological classification of PanNET now relies only on the proliferative activity (mitosis and Ki67) and staging. In contrast to other endocrine neoplasms, the role of infiltrative growth pattern in NF-PanNET is not taken into consideration at present. In the current study, 247 consecutive patients who underwent surgical resection for a NF-PanNET were examined for the histological growth pattern of the tumor. Two distinct patterns (non-infiltrative vs. infiltrative) were described with the latter being further subclassified according to the type of structures invaded by the tumor (non-infiltrative: pattern 1; infiltration of adjacent pancreatic parenchyma and/or peripancreatic soft tissue: pattern 2; invasion of nearby organs and/or major vessels: pattern 3). The infiltrative growth resulted to be strongly associated with a poorer survival compared to a non-infiltrative growth (p < 0.001). In particular, the distinction between pancreatic parenchyma and/or peripancreatic soft tissue invasion versus adjacent organs and/or major vessels invasion was the most powerful predictor of recurrence after surgery at multivariate analysis (pattern 2 vs. pattern 1: HR 10.136, p = 0.028; pattern 3 vs. pattern 1: HR 15.775, p = 0.015). The infiltrative growth pattern could therefore provide additional prognostic information implementing the current grading and staging system.
Keywords: Infiltrative tumor growth; Pancreatic neuroendocrine tumor; Vascular invasion.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- De Lellis RA, Lloyd RV, Heitz PU et al. WHO Classification of Tumours, Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press, editor. 2004.
-
- WHO Classification of Tumours Editorial Board, Digestive System Tumours, 5th ed. Lyon: IARC Press; 2019.
-
- Strosberg JR, Cheema A, Weber JM, Ghayouri M, Han G, Hodul PJ and Kvols LK. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: An analysis of the AJCC and ENETS staging classifications. Ann Surg. 2012;256(2):321–5. https://doi.org/10.1097/SLA.0b013e31824e6108 . - DOI - PubMed
-
- Partelli S, Landoni L, Andreasi V, Nessi C, Muffatti F, Crippa S et al. Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors. Surgery. 2020 Nov; 168(5):816–24. https://doi.org/10.1016/j.surg.2020.06.034 . - DOI - PubMed
-
- Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S et al. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. Ann Surg. 2019;270(3):422–33. https://doi.org/10.1097/SLA.0000000000003461 . - DOI - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
